Characterization

After screening and selection and any post-translational modifications, we can further characterize the selected nanobodies as desired. Determining the affinity, specificity and selectivity for the target. Initially, this is often the same cloned protein with which the screening and selection was carried out, and then tested in an ELISA or SPR setup. But it can also be extended to binding to cell fragments, whole cells or tissue.